The proposed bill, if enacted, would amend existing Arizona statutes to prohibit health care insurers from imposing cost-sharing requirements for diagnostic prostate cancer screenings for high-risk subscribers starting January 1, 2027. This change would apply to various types of insurers, including hospital service corporations, medical service corporations, disability insurers, and group disability insurers. The bill defines "high-risk" as men aged 40 and older who meet specific criteria, such as being of African ancestry, carrying the BRCA1 or BRCA2 gene, having a family history of prostate cancer, or being military veterans exposed to Agent Orange.

Additionally, the bill clarifies that the prohibition on cost-sharing does not extend to out-of-network screenings. It also expands the definition of family history to include first-degree relatives diagnosed with prostate cancer under the age of 60, those who died of prostate cancer, or those who developed other cancers associated with an increased risk of prostate cancer. The bill aims to enhance access to necessary screenings for high-risk individuals without the financial burden of cost-sharing.

Statutes affected:
Introduced Version: 20-841.14, 20-1057.21, 20-1376.11, 20-1406.11
House Engrossed Version: 20-841.14, 20-1057.21, 20-1376.11, 20-1406.11